These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18855770)

  • 1. Monitoring helicase activity with molecular beacons.
    Belon CA; Frick DN
    Biotechniques; 2008 Oct; 45(4):433-40, 442. PubMed ID: 18855770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and analysis of inhibitors targeting the hepatitis C virus NS3 helicase.
    Hanson AM; Hernandez JJ; Shadrick WR; Frick DN
    Methods Enzymol; 2012; 511():463-83. PubMed ID: 22713333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time monitoring of RNA helicase activity using fluorescence resonance energy transfer in vitro.
    Tani H; Fujita O; Furuta A; Matsuda Y; Miyata R; Akimitsu N; Tanaka J; Tsuneda S; Sekiguchi Y; Noda N
    Biochem Biophys Res Commun; 2010 Feb; 393(1):131-6. PubMed ID: 20117090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fluorescence-based screening assay for identification of hepatitis C virus NS3 helicase inhibitors and characterization of their inhibitory mechanism.
    Furuta A; Salam KA; Tani H; Tsuneda S; Sekiguchi Y; Akimitsu N; Noda N
    Methods Mol Biol; 2015; 1259():211-28. PubMed ID: 25579589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorometric assay of hepatitis C virus NS3 helicase activity.
    Krawczyk M; Stankiewicz-Drogoń A; Haenni AL; Boguszewska-Chachulska A
    Methods Mol Biol; 2010; 587():211-21. PubMed ID: 20225152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fuel specificity of the hepatitis C virus NS3 helicase.
    Belon CA; Frick DN
    J Mol Biol; 2009 May; 388(4):851-64. PubMed ID: 19332076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro selection of RNA aptamers against the HCV NS3 helicase domain.
    Nishikawa F; Funaji K; Fukuda K; Nishikawa S
    Oligonucleotides; 2004; 14(2):114-29. PubMed ID: 15294075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C Virus Helicase Binding Activity Monitored through Site-Specific Labeling Using an Expanded Genetic Code.
    Ablenas CJ; Gidi Y; Powdrill MH; Ahmed N; Shaw TA; Mesko M; Götte M; Cosa G; Pezacki JP
    ACS Infect Dis; 2019 Dec; 5(12):2118-2126. PubMed ID: 31640339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism and specificity of a symmetrical benzimidazolephenylcarboxamide helicase inhibitor.
    Belon CA; High YD; Lin TI; Pauwels F; Frick DN
    Biochemistry; 2010 Mar; 49(9):1822-32. PubMed ID: 20108979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput screening assay of hepatitis C virus helicase inhibitors using fluorescence-quenching phenomenon.
    Tani H; Akimitsu N; Fujita O; Matsuda Y; Miyata R; Tsuneda S; Igarashi M; Sekiguchi Y; Noda N
    Biochem Biophys Res Commun; 2009 Feb; 379(4):1054-9. PubMed ID: 19150342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific interaction of hepatitis C virus protease/helicase NS3 with the 3'-terminal sequences of viral positive- and negative-strand RNA.
    Banerjee R; Dasgupta A
    J Virol; 2001 Feb; 75(4):1708-21. PubMed ID: 11160669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NS3 helicase actively separates RNA strands and senses sequence barriers ahead of the opening fork.
    Cheng W; Dumont S; Tinoco I; Bustamante C
    Proc Natl Acad Sci U S A; 2007 Aug; 104(35):13954-9. PubMed ID: 17709749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct fluorometric measurement of hepatitis C virus helicase activity.
    Boguszewska-Chachulska AM; Krawczyk M; Stankiewicz A; Gozdek A; Haenni AL; Strokovskaya L
    FEBS Lett; 2004 Jun; 567(2-3):253-8. PubMed ID: 15178332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suramin inhibits helicase activity of NS3 protein of dengue virus in a fluorescence-based high throughput assay format.
    Basavannacharya C; Vasudevan SG
    Biochem Biophys Res Commun; 2014 Oct; 453(3):539-44. PubMed ID: 25281902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus subgenomic replicon requires an active NS3 RNA helicase.
    Lam AM; Frick DN
    J Virol; 2006 Jan; 80(1):404-11. PubMed ID: 16352565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and analysis of hepatitis C virus NS3 helicase inhibitors using nucleic acid binding assays.
    Mukherjee S; Hanson AM; Shadrick WR; Ndjomou J; Sweeney NL; Hernandez JJ; Bartczak D; Li K; Frankowski KJ; Heck JA; Arnold LA; Schoenen FJ; Frick DN
    Nucleic Acids Res; 2012 Sep; 40(17):8607-21. PubMed ID: 22740655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust translocation along a molecular monorail: the NS3 helicase from hepatitis C virus traverses unusually large disruptions in its track.
    Beran RK; Bruno MM; Bowers HA; Jankowsky E; Pyle AM
    J Mol Biol; 2006 May; 358(4):974-82. PubMed ID: 16569413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel high throughput screening assay for HCV NS3 helicase activity.
    Hicham Alaoui-Ismaili M; Gervais C; Brunette S; Gouin G; Hamel M; Rando RF; Bedard J
    Antiviral Res; 2000 Jun; 46(3):181-93. PubMed ID: 10867156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic Interconversions of HCV Helicase Binding Modes on the Nucleic Acid Substrate.
    Ablenas CJ; Liu HW; Shkriabai N; Kvaratskhelia M; Cosa G; Götte M
    ACS Infect Dis; 2017 Jan; 3(1):99-109. PubMed ID: 28081608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of robust in vitro serine protease assay based on recombinant Pakistani HCV NS3-4A protease.
    Fatima K; Tahir M; Qadri I
    Virus Res; 2011 Sep; 160(1-2):230-7. PubMed ID: 21756947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.